Adiponectin and Risk of Congestive Heart Failure
- 19 April 2006
- journal article
- letter
- Published by American Medical Association (AMA)
- Vol. 295 (15), 1769-1774
- https://doi.org/10.1001/jama.295.15.1772-c
Abstract
To the Editor: We recently reported that insulin resistance is an independent predictor of congestive heart failure (CHF).1 In a subsequent Letter to the Editor, Stefan et al2 proposed adiponectin as a mediator of that association. Low adiponectin concentration has been associated with risk of myocardial infarction.3 We therefore investigated in our cohort (Uppsala Longitudinal Study of Adult Men) whether circulating adiponectin (primary hypothesis) or single nucleotide polymorphisms (SNPs) in the adiponectin gene ADIPOQ (secondary hypothesis) predict incident CHF.Keywords
This publication has 7 references indexed in Scilit:
- Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart FailureCirculation, 2005
- Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolismCardiovascular Research, 2005
- Insulin Resistance and Risk of Congestive Heart FailureJAMA, 2005
- The +276 Polymorphism of the APM1 Gene, Plasma Adiponectin Concentration, and Cardiovascular Risk in Diabetic MenDiabetes, 2005
- Plasma Adiponectin Levels and Risk of Myocardial Infarction in MenJAMA, 2004
- Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin SensitivityJournal of Biological Chemistry, 2004
- A New Statistical Method for Haplotype Reconstruction from Population DataAmerican Journal of Human Genetics, 2001